Patents by Inventor Markus Hansson

Markus Hansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTIBODIES AGAINST ICAM-1 IN COMBINATION WITH AN ANTI CANCER DRUG IN THE TREATMENT OF PATIENTS
    Publication number: 20180221482
    Abstract: There is provided antibodies or antigen-binding fragments thereof with binding specificity for ICAM-1, together with further anti-cancer agents, and compositions thereof, for use in the treatment of cancer.
    Type: Application
    Filed: December 19, 2017
    Publication date: August 9, 2018
    Applicant: BioInvent International AB
    Inventors: Björn Frendéus, Markus Hansson
  • USE OF ANTIBODIES AGAINST ICAM-1 IN THE TREATMENT OF PATIENTS WITH RELAPSED CANCER
    Publication number: 20160280788
    Abstract: There is provided antibodies or antigen-binding fragments thereof with binding specificity for ICAM-1, for use in the treatment of cancer in patients who have previously been treated for cancer and either not responded to said treatment or have previously responded to said treatment and subsequently relapsed.
    Type: Application
    Filed: January 27, 2016
    Publication date: September 29, 2016
    Applicant: BioInvent International AB
    Inventors: Markus Hansson, Björn Frendéus
  • USE OF ANTIBODIES AGAINST ICAM-1 IN COMBINATION WITH AN ANTI CANCER DRUG IN THE TREATMENT OF PATIENTS
    Publication number: 20150352207
    Abstract: There is provided antibodies or antigen-binding fragments thereof with binding specificity for ICAM-1, together with further anti-cancer agents, and compositions thereof, for use in the treatment of cancer.
    Type: Application
    Filed: January 9, 2014
    Publication date: December 10, 2015
    Inventors: Björn Frendeus, Markus Hansson
  • ANTI-ICAM-1 ANTIBODIES TO TREAT MULTIPLE-MYELOMA RELATED DISORDERS
    Publication number: 20140242072
    Abstract: The invention relates to the use of an antibody or an antigen-binding fragment thereof with binding specificity for ICAM-1, or a variant, fusion or derivative of said antibody or an antigen-binding fragment with binding specificity for ICAM-1, for the treatment of a multiple-myeloma-related disorder. The invention also relates to methods for the administration of such antibodies, fragments, variants, fusion and derivatives thereof.
    Type: Application
    Filed: September 27, 2012
    Publication date: August 28, 2014
    Applicant: BIOINVENT INTERNATIONAL AB
    Inventor: Markus Hansson
  • USE OF ANTIBODIES AGAINST ICAM-1 IN THE TREATMENT OF PATIENTS WITH RELAPSED CANCER
    Publication number: 20130189260
    Abstract: There is provided antibodies or antigen-binding fragments thereof with binding specificity for ICAM-1, for use in the treatment of cancer in patients who have previously been treated for cancer and either not responded to said treatment or have previously responded to said treatment and subsequently relapsed.
    Type: Application
    Filed: July 13, 2011
    Publication date: July 25, 2013
    Inventors: Markus Hansson, Bjorn Frendeus